• Home
• About Us
• Events
• News
• Recent Contributions
• CMReJournal

• CMR Short Reviews
  • The Concept of CMR

    Historical background on global cardiometabolic risk, epidemiological aspects of obesity and type 2 diabetes, ABCs of cardiovascular disease risk factors, intra-abdominal adiposity, metabolic syndrome and contribution to cardiometabolic risk.

    • Definition and History
    • The Obesity and Type 2 Diabetes Epidemics
    • Epidemiology
    • Intra-abdominal Adipose Tissue: the Culprit?
    • Intra-abdominal Obesity and Cardiometabolic Risk
  • Evaluating CMR

    Research and clinical tools to identify individuals with excess intra-abdominal adiposity and quantify their risk of diabetes and cardiovascular disease (global cardiometabolic risk).

    • Clinical Tools
    • Imaging Techniques
    • Assessing CVD Risk: Traditional Approaches
    • Metabolic Syndrome and Type 2 Diabetes/CVD Risk
    • Assessing Cardiometabolic Risk
  • Managing CMR

    Notions and practical tools to better manage the abdominally obese patient with excess intra-abdominal adiposity and related clustering abnormalities.

    • Targeting Traditional CVD Risk Factors in Patients With Abdominal Obesity
    • Residual Cardiometabolic Risk of Treated Patients
    • Effects of Weight Loss on Adipose Tissue Distribution
    • Managing CMR in Abdominally Obese Patients
    • Preventing Type 2 Diabetes
• Documentation Centre
  •  Slides, videos and more
    • Slide Library
    • Expert Opinions
    • Webcasts
    • Key Publications
    • Image Base
    • Advanced Search

• Home
• Managing CMR
• Targeting Traditional CVD Risk Factors in Patients With Abdominal Obesity
• Lipids

Managing CMR

Targeting Traditional CVD Risk Factors in Patients With Abdominal Obesity

Lipids

• 1Publications (1 page)
• 2Websites (1 page)

Websites

Page: 2 of 2

---

American Heart Association (AHA)
Statements, Guidelines and Clinical Updates - Cholesterol

European Society of Cardiology (ESC)
ESC Clinical Practice Guidelines

International Task Force for Prevention of Coronary Heart Disease
Guidelines

National Heart Lung and Blood Institute – National Institutes of Health (NHLBI – NIH)
Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Heart Foundation (Australia)
Lipid Management

National Institute for Health and Clinical Excellence (NICE)
Lipid Modification

---

Page: 2 of 2

Print this document

• Contact Us
• Site Map
• Links
• Our Partners
• Press Room
• Legal Notices

© 2012, International Chair on Cardiometabolic Risk